Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2026-01-03 @ 1:32 AM
Study NCT ID:
NCT01892293
Status:
TERMINATED
Last Update Posted:
2019-01-10
First Post:
2013-06-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
CT Antigen TCR-Engineered T Cells for Myeloma
Sponsor:
Adaptimmune
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-15
Start Date Type:
ACTUAL
Primary Completion Date:
2014-12-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04-09
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-27
First Submit QC Date:
None
Study First Post Date:
2013-07-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-03-20
Results First Submit QC Date:
None
Results First Post Date:
2018-07-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-08
Last Update Post Date:
2019-01-10
Last Update Post Date Type:
ACTUAL